Circulating microparticles levels are increased in patients with diabetic kidney disease: A case-control research

Clin Chim Acta. 2018 Apr:479:48-55. doi: 10.1016/j.cca.2017.12.048. Epub 2018 Jan 3.

Abstract

Background: Type 2 diabetes mellitus (T2DM) is associated with chronic lowgrade inflammation. Microparticles (MPs) are extracellular microvesicles released during apoptosis and cellular activation. The MP's pro-coagulant and pro-inflammatory activities are involved in endothelial dysfunction observed in T2DM patients. This study aimed to evaluate the circulating MPs profile in T2DM patients with diabetic kidney disease (DKD) and correlate it with clinical and laboratorial parameters.

Methods: MPs derived from platelets (PMPs), leukocytes (LMPs), endothelial cells (EMPs), and expressing tissue factor (TFMPs) were measured by flow cytometry, in plasma of 39 DKD patients and 30 non-diabetic controls.

Results: We observed higher PMPs, LMPs, EMPs, and TFMPs (all p<0.0001) levels in case group as compared to controls. For patients with DKD, circulating MPs levels were influenced by gender, but not by obesity status nor by T2DM onset. Fasting glucose and 25-hydroxyvitamin D levels showed correlation with circulating MPs levels in both groups.

Conclusions: These results suggest that type 2 diabetes mellitus patients with DKD presented higher circulating MPs levels - PMPs, LMPs, EMPs, and TFMPs - which correlated with metabolic alterations.

Keywords: Diabetic kidney disease; Inflammation; Microparticles; Obesity; Type 2 diabetes mellitus; Vitamin D.

MeSH terms

  • Case-Control Studies
  • Cell-Derived Microparticles / chemistry*
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetic Nephropathies / blood*
  • Diabetic Nephropathies / diagnosis
  • Female
  • Humans
  • Kidney Diseases / blood*
  • Kidney Diseases / diagnosis
  • Male
  • Middle Aged